Nabota 200U
Nabota 200U is a Type A botulinum toxin developed by Daewoong Pharmaceutical Co., Ltd. and approved by the United States Food and Drug Administration (FDA). As the first Korean botulinum toxin to enter the American market, Nabota competes directly with Botox as a cost-effective alternative that does not require changing the way this potentially toxic substance is handled.
Active Ingredient
Clostridium Type A botulinum toxin (strain: Clostridium Botulinum CBFC26)
Units
200 units
Packaging
1 vial of 200 units per box
Description
The Type A botulinum toxin Nabota is used to combat the appearance of wrinkles that develop due to uncontrolled muscle tone in the face and active facial expressions. Nabota is a proven, safe and reliable product, developed by Daewoong Pharmaceutical Co., Ltd., South Korea, with more than 30 years of experience in biotechnology.- Rapid action
- High standard of cleanliness
- Long-lasting effects
- It does not “freeze” facial expressions
- High safety
Application Areas
- Smoothing of wrinkles in the eyebrow region, nasolabial folds, wrinkles around the eyes and mouth, periorbital areas
- Elimination of blepharospasm
- Elimination of hyperhidrosis
- Lifting with Botox
| Active Ingredient | Clostridium Type A botulinum toxin (strain: Clostridium Botulinum CBFC26) |
|---|---|
| Units | 200 units |
| Packaging | 1 vial of 200 units per box |
Recommended Archive
Hutox 100U
Hutox 100U is a Type A botulinum toxin from South Korea's largest pharmaceutical company, Huons Global Co., Ltd.,…
59$
Rentox 100U
We present ReNTox 100 units: it is an innovative Premium Class drug based on Type A botulinum toxin,…
61$
Liztox 200U
Liztox is a highly purified form of Type A botulinum toxin, obtained from the Clostridium bacterium. It is…
78$